Earlier Phase 2 Data and Wider Programme The new TRIUMPH-1 results build on earlier Phase 2 data published in The New England Journal of Medicine , which showed an average weight loss of around 24.2% at 48 weeks in adults with obesity
(13) V I Odin, T V Belikova, E S Pushkova, N A Barr (2004) [Diabetes mellitus in elderly: geroprotective and antidiabetic properties of delta-sleep induced peptide] Advances in Gerontology, 2004, Volume 15, Pages 101-14
This potent vasodilator is critical in regulating capillary tone and maintaining vascular patency
"We know that weight loss can significantly improve symptoms of sleep apnea," points out Atul Malhotra, MD, a sleep medicine specialist at UC San Diego Health
This advanced daily formula pairs pharmaceutical-grade BPC 157 (Body Protection Compound) with a synergistic blend of magnesium, creatine monohydrate, collagen peptides, and antioxidants delivering comprehensive support for recovery, resilience, and long-term wellness in just two capsules a day
